Concepedia

Author

Ute Hegenbart

Heidelberg UniversityORCID

Also Known As

Hegenbart U, Hegenbart U., Hegenbart, U., Hegenbart, Ute, T Luft, U Hegenbart, U. Hegenbart, Ute Hegenbart

476

Publications

16.7K

Citations

66

H-Index

140

Concepts

All Affiliations

Heidelberg UniversityUniversity Hospital HeidelbergGerman Cancer Research CenterNational Center for Tumor DiseasesUniversity of Pavia
UH

About

Ute Hegenbart is an author at Heidelberg University specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

36

69

3.7K

2

Health Sciences

16

18

1.1K

3

Public Health

4

4

100

4

Natural Sciences

2

2

109

5

Social Sciences

1

1

20

Ute Hegenbart

×

194

Publications

15.5K

Citations

63

H-Index

YearCitations

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

Peter A. McSweeney, Dietger Niederwieser, Judith A. Shizuru,

Blood

2001

1.4K

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

Giovanni Palladini, Angela Dispenzieri, Morie A. Gertz,

Journal of Clinical Oncology

2012

928

A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis

Ashutosh Wechalekar, Stefan Schönland, Efstathios Kastritis,

Blood

2013

505

A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

Giovanni Palladini, Ute Hegenbart, Paolo Milani,

Blood

2014

492

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

Dietger Niederwieser, Michael B. Maris, Judith A. Shizuru,

Blood

2003

455

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

David G. Maloney, Arthur J. Molina, Firoozeh Sahebi,

Blood

2003

406

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Michael B. Maris, Dietger Niederwieser, Brenda M. Sandmaier,

Blood

2003

335

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

Peter Dreger, Hartmut Döhner, Matthias Ritgen,

Blood

2010

302

Longitudinal Left Ventricular Function for Prediction of Survival in Systemic Light-Chain Amyloidosis

Sebastian J. Buss, Mostafa Emami, Derliz Mereles,

Journal of the American College of Cardiology

2012

279

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

Martin Bornhäuser, Joachim Kienast, Rudolf Trenschel,

The Lancet Oncology

2012

269

Page 1